What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article
Roche acquires a workflow rather than a company, says AI industry observer
Start a Free Trial for immediate access to this article